HDAC1 and colorectal cancer: However, the OS rate was comparable between patients with low HDAC1 expression and those with high HDAC1 expression in colorectal cancer (HR = 0.87, 95% CI = 0.66–1.13, P = 0.30) (Figure 9A), liver cancer (HR = 1.71, 95% CI = 0.76–3.86, P = 0.19) (Figure 9C) and pancreatic cancer (HR = 1.43, 95% CI = 0.71–2.88, P = 0.32) (Figure 9D).